Cargando…

Effects of a remote patient monitoring system for patients on automated peritoneal dialysis: a randomized crossover controlled trial

PURPOSE: Remote patient monitoring (RPM) has contributed to improved patient-centered outcomes and prognosis in patients with end-stage renal disease on automated peritoneal dialysis (APD). However, evidence from prospective trials is lacking. METHODS: The participants (n = 15; median age: 65 years;...

Descripción completa

Detalles Bibliográficos
Autores principales: Uchiyama, Kiyotaka, Morimoto, Kohkichi, Washida, Naoki, Kusahana, Ei, Nakayama, Takashin, Itoh, Tomoaki, Kasai, Takahiro, Wakino, Shu, Itoh, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972739/
https://www.ncbi.nlm.nih.gov/pubmed/35362819
http://dx.doi.org/10.1007/s11255-022-03178-5
_version_ 1784679912171372544
author Uchiyama, Kiyotaka
Morimoto, Kohkichi
Washida, Naoki
Kusahana, Ei
Nakayama, Takashin
Itoh, Tomoaki
Kasai, Takahiro
Wakino, Shu
Itoh, Hiroshi
author_facet Uchiyama, Kiyotaka
Morimoto, Kohkichi
Washida, Naoki
Kusahana, Ei
Nakayama, Takashin
Itoh, Tomoaki
Kasai, Takahiro
Wakino, Shu
Itoh, Hiroshi
author_sort Uchiyama, Kiyotaka
collection PubMed
description PURPOSE: Remote patient monitoring (RPM) has contributed to improved patient-centered outcomes and prognosis in patients with end-stage renal disease on automated peritoneal dialysis (APD). However, evidence from prospective trials is lacking. METHODS: The participants (n = 15; median age: 65 years; males: 10; peritoneal dialysis vintage: 6.4 ± 3.5 years) randomly received APD therapy using the Kaguya® APD system either with or without the connective use of the cloud-based RPM software Sharesource® for 12 weeks. The primary outcome was patient satisfaction assessed using a modified nine-item Treatment Satisfaction Questionnaire for Medication (TSQM-9) questionnaire. The secondary outcomes were healthcare resource consumption, the health-related quality of life (HRQOL) subscales assessed with the Kidney Disease Quality of Life-Short Form questionnaire, and clinical laboratory parameters. RESULTS: Significant improvements were observed in the TSQM-9 subscales of Effectiveness (64.4 ± 18.8 vs. 57.8 ± 18.8; P = 0.006) and Convenience (76.3 ± 15.4 vs. 63.3 ± 17.3; P < 0.001) in patients on Sharesource®. Moreover, Sharesource® reduced the total amount of healthcare resource consumption (0.80 ± 1.32 vs. 1.87 ± 2.39 times/12 weeks; P = 0.02) and consultation time during regular monthly visits (813 ± 269 vs. 1024 ± 292 s; P < 0.001). A significant increase in ultrafiltration volume was found associated with more frequent modification of APD prescription in patients with Sharesource®. Sharesource® also improved the HRQOL subscale of General Health and Vitality. CONCLUSION: Sharesource® can improve patient-centered outcomes in patients on APD while reducing the treatment burden for both patients and medical staff. Trial registration: The study was registered in the Japan Registry of Clinical Trials (jRCT Number: jRCTs032190005). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11255-022-03178-5.
format Online
Article
Text
id pubmed-8972739
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-89727392022-04-01 Effects of a remote patient monitoring system for patients on automated peritoneal dialysis: a randomized crossover controlled trial Uchiyama, Kiyotaka Morimoto, Kohkichi Washida, Naoki Kusahana, Ei Nakayama, Takashin Itoh, Tomoaki Kasai, Takahiro Wakino, Shu Itoh, Hiroshi Int Urol Nephrol Nephrology - Original Paper PURPOSE: Remote patient monitoring (RPM) has contributed to improved patient-centered outcomes and prognosis in patients with end-stage renal disease on automated peritoneal dialysis (APD). However, evidence from prospective trials is lacking. METHODS: The participants (n = 15; median age: 65 years; males: 10; peritoneal dialysis vintage: 6.4 ± 3.5 years) randomly received APD therapy using the Kaguya® APD system either with or without the connective use of the cloud-based RPM software Sharesource® for 12 weeks. The primary outcome was patient satisfaction assessed using a modified nine-item Treatment Satisfaction Questionnaire for Medication (TSQM-9) questionnaire. The secondary outcomes were healthcare resource consumption, the health-related quality of life (HRQOL) subscales assessed with the Kidney Disease Quality of Life-Short Form questionnaire, and clinical laboratory parameters. RESULTS: Significant improvements were observed in the TSQM-9 subscales of Effectiveness (64.4 ± 18.8 vs. 57.8 ± 18.8; P = 0.006) and Convenience (76.3 ± 15.4 vs. 63.3 ± 17.3; P < 0.001) in patients on Sharesource®. Moreover, Sharesource® reduced the total amount of healthcare resource consumption (0.80 ± 1.32 vs. 1.87 ± 2.39 times/12 weeks; P = 0.02) and consultation time during regular monthly visits (813 ± 269 vs. 1024 ± 292 s; P < 0.001). A significant increase in ultrafiltration volume was found associated with more frequent modification of APD prescription in patients with Sharesource®. Sharesource® also improved the HRQOL subscale of General Health and Vitality. CONCLUSION: Sharesource® can improve patient-centered outcomes in patients on APD while reducing the treatment burden for both patients and medical staff. Trial registration: The study was registered in the Japan Registry of Clinical Trials (jRCT Number: jRCTs032190005). SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11255-022-03178-5. Springer Netherlands 2022-04-01 2022 /pmc/articles/PMC8972739/ /pubmed/35362819 http://dx.doi.org/10.1007/s11255-022-03178-5 Text en © The Author(s), under exclusive licence to Springer Nature B.V. 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Nephrology - Original Paper
Uchiyama, Kiyotaka
Morimoto, Kohkichi
Washida, Naoki
Kusahana, Ei
Nakayama, Takashin
Itoh, Tomoaki
Kasai, Takahiro
Wakino, Shu
Itoh, Hiroshi
Effects of a remote patient monitoring system for patients on automated peritoneal dialysis: a randomized crossover controlled trial
title Effects of a remote patient monitoring system for patients on automated peritoneal dialysis: a randomized crossover controlled trial
title_full Effects of a remote patient monitoring system for patients on automated peritoneal dialysis: a randomized crossover controlled trial
title_fullStr Effects of a remote patient monitoring system for patients on automated peritoneal dialysis: a randomized crossover controlled trial
title_full_unstemmed Effects of a remote patient monitoring system for patients on automated peritoneal dialysis: a randomized crossover controlled trial
title_short Effects of a remote patient monitoring system for patients on automated peritoneal dialysis: a randomized crossover controlled trial
title_sort effects of a remote patient monitoring system for patients on automated peritoneal dialysis: a randomized crossover controlled trial
topic Nephrology - Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972739/
https://www.ncbi.nlm.nih.gov/pubmed/35362819
http://dx.doi.org/10.1007/s11255-022-03178-5
work_keys_str_mv AT uchiyamakiyotaka effectsofaremotepatientmonitoringsystemforpatientsonautomatedperitonealdialysisarandomizedcrossovercontrolledtrial
AT morimotokohkichi effectsofaremotepatientmonitoringsystemforpatientsonautomatedperitonealdialysisarandomizedcrossovercontrolledtrial
AT washidanaoki effectsofaremotepatientmonitoringsystemforpatientsonautomatedperitonealdialysisarandomizedcrossovercontrolledtrial
AT kusahanaei effectsofaremotepatientmonitoringsystemforpatientsonautomatedperitonealdialysisarandomizedcrossovercontrolledtrial
AT nakayamatakashin effectsofaremotepatientmonitoringsystemforpatientsonautomatedperitonealdialysisarandomizedcrossovercontrolledtrial
AT itohtomoaki effectsofaremotepatientmonitoringsystemforpatientsonautomatedperitonealdialysisarandomizedcrossovercontrolledtrial
AT kasaitakahiro effectsofaremotepatientmonitoringsystemforpatientsonautomatedperitonealdialysisarandomizedcrossovercontrolledtrial
AT wakinoshu effectsofaremotepatientmonitoringsystemforpatientsonautomatedperitonealdialysisarandomizedcrossovercontrolledtrial
AT itohhiroshi effectsofaremotepatientmonitoringsystemforpatientsonautomatedperitonealdialysisarandomizedcrossovercontrolledtrial